Pomadomide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pomadomide, covering 2024-08-15 to 2024-08-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma [Phase 1, Phase 2]